Summary3Cytokine: /home/Demos/Flow/demo/Peptide Validation

Summary3Cytokine

Peptide Validation

PROTOCOL Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	LABID Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	ASSAYID Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	Sample Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	ICS blinded Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	SPECIMEN COLLECTION DATE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	THAW DATE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	ASSAYRUN Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	RELIABLE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	PLATE TEMPLATE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	PLATE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	Sample order Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	WELL ID Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	COLLECTCT Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	SINGLETCT Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	LIVECT Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	LYMPHCT Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	CD3CT Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	TCELLSUB Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	NSUB Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	ANTIGEN Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	CYTOKINE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	PFD Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	CYTNUM Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	NREPL Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	METHOD Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Box & Whisker Quick Chart	STAIN Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	REPLACE Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	Analysis Results Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart	FCSFile Name Sort Ascending Sort Descending Clear Sort Filter... Clear Filter Remove Column Summary Statistics... Bar Chart Pie Chart Quick Chart
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD4	60,234	Neg Cont	IFN-IL2-TNF+	1	12	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD4	60,234	Neg Cont	IFN-IL2+TNF+	2	12	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD4	60,234	Neg Cont	IFN+IL2-TNF-	1	2	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD4	60,234	Neg Cont	IFN+IL2-TNF+	2	0	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD4	60,234	Neg Cont	IFN+IL2+TNF-	2	6	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD4	60,234	Neg Cont	IFN+IL2+TNF+	3	2	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD8	55,613	Neg Cont	IFN-IL2-TNF-	0	55,607	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD8	55,613	Neg Cont	IFN-IL2-TNF+	1	1	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD8	55,613	Neg Cont	IFN-IL2+TNF+	2	0	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD8	55,613	Neg Cont	IFN+IL2-TNF-	1	4	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD8	55,613	Neg Cont	IFN+IL2-TNF+	2	0	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD8	55,613	Neg Cont	IFN+IL2+TNF-	2	0	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD8	55,613	Neg Cont	IFN+IL2+TNF+	3	0	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD4	60,234	Neg Cont	IFN-IL2+TNF-	1	13	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A01	256,516	249,082	222,602	176,615	123,591	CD8	55,613	Neg Cont	IFN-IL2+TNF-	1	1	1	1	S	N	9259	118771.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD4	60,184	Neg Cont	IFN-IL2-TNF-	0	60,124	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD4	60,184	Neg Cont	IFN-IL2-TNF+	1	10	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD4	60,184	Neg Cont	IFN-IL2+TNF+	2	10	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD4	60,184	Neg Cont	IFN+IL2-TNF-	1	13	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD4	60,184	Neg Cont	IFN+IL2-TNF+	2	0	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD4	60,184	Neg Cont	IFN+IL2+TNF-	2	8	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD4	60,184	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD8	54,692	Neg Cont	IFN-IL2-TNF-	0	54,688	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD8	54,692	Neg Cont	IFN-IL2-TNF+	1	1	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD8	54,692	Neg Cont	IFN-IL2+TNF+	2	0	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD8	54,692	Neg Cont	IFN+IL2-TNF-	1	2	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD8	54,692	Neg Cont	IFN+IL2-TNF+	2	0	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD8	54,692	Neg Cont	IFN+IL2+TNF-	2	1	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD8	54,692	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD4	60,184	Neg Cont	IFN-IL2+TNF-	1	19	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-1	ICS001	Blinded	2006-03-27 00:00	Y	Y	A	P1	1	A02	248,872	242,783	219,180	173,982	122,205	CD8	54,692	Neg Cont	IFN-IL2+TNF-	1	0	2	1	S	N	9261	118773.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD4	56,366	Neg Cont	IFN-IL2-TNF-	0	56,353	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD4	56,366	Neg Cont	IFN-IL2-TNF+	1	1	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD4	56,366	Neg Cont	IFN-IL2+TNF+	2	0	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD4	56,366	Neg Cont	IFN+IL2-TNF-	1	6	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD4	56,366	Neg Cont	IFN+IL2-TNF+	2	0	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD4	56,366	Neg Cont	IFN+IL2+TNF-	2	4	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD4	56,366	Neg Cont	IFN+IL2+TNF+	3	0	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD8	29,235	Neg Cont	IFN-IL2-TNF-	0	29,226	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD8	29,235	Neg Cont	IFN-IL2-TNF+	1	2	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD8	29,235	Neg Cont	IFN-IL2+TNF+	2	0	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD8	29,235	Neg Cont	IFN+IL2-TNF-	1	6	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD8	29,235	Neg Cont	IFN+IL2-TNF+	2	0	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD8	29,235	Neg Cont	IFN+IL2+TNF-	2	1	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD8	29,235	Neg Cont	IFN+IL2+TNF+	3	0	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD4	56,366	Neg Cont	IFN-IL2+TNF-	1	2	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B01	206,440	200,692	175,127	128,429	90,753	CD8	29,235	Neg Cont	IFN-IL2+TNF-	1	0	1	1	S	N	9260	118777.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD4	50,023	Neg Cont	IFN-IL2-TNF-	0	50,014	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD4	50,023	Neg Cont	IFN-IL2-TNF+	1	2	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD4	50,023	Neg Cont	IFN-IL2+TNF+	2	0	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD4	50,023	Neg Cont	IFN+IL2-TNF-	1	4	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD4	50,023	Neg Cont	IFN+IL2-TNF+	2	0	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD4	50,023	Neg Cont	IFN+IL2+TNF-	2	3	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD4	50,023	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD8	25,880	Neg Cont	IFN-IL2-TNF-	0	25,877	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD8	25,880	Neg Cont	IFN-IL2-TNF+	1	0	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD8	25,880	Neg Cont	IFN-IL2+TNF+	2	0	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD8	25,880	Neg Cont	IFN+IL2-TNF-	1	1	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD8	25,880	Neg Cont	IFN+IL2-TNF+	2	0	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD8	25,880	Neg Cont	IFN+IL2+TNF-	2	2	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD8	25,880	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD4	50,023	Neg Cont	IFN-IL2+TNF-	1	0	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-2	ICS002	Blinded	2006-03-27 00:00	Y	Y	A	P1	2	B02	183,690	179,373	153,749	113,969	80,516	CD8	25,880	Neg Cont	IFN-IL2+TNF-	1	0	2	1	S	N	9262	118779.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD4	63,327	Neg Cont	IFN-IL2-TNF-	0	63,292	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD4	63,327	Neg Cont	IFN-IL2-TNF+	1	1	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD4	63,327	Neg Cont	IFN-IL2+TNF+	2	2	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD4	63,327	Neg Cont	IFN+IL2-TNF-	1	16	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD4	63,327	Neg Cont	IFN+IL2-TNF+	2	1	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD4	63,327	Neg Cont	IFN+IL2+TNF-	2	9	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD4	63,327	Neg Cont	IFN+IL2+TNF+	3	0	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD8	64,606	Neg Cont	IFN-IL2-TNF-	0	64,592	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD8	64,606	Neg Cont	IFN-IL2-TNF+	1	1	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD8	64,606	Neg Cont	IFN-IL2+TNF+	2	0	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD8	64,606	Neg Cont	IFN+IL2-TNF-	1	8	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD8	64,606	Neg Cont	IFN+IL2-TNF+	2	3	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD8	64,606	Neg Cont	IFN+IL2+TNF-	2	2	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD8	64,606	Neg Cont	IFN+IL2+TNF+	3	0	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD4	63,327	Neg Cont	IFN-IL2+TNF-	1	6	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C01	248,014	241,553	217,734	191,670	145,036	CD8	64,606	Neg Cont	IFN-IL2+TNF-	1	0	1	1	S	N	9263	118783.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD4	64,761	Neg Cont	IFN-IL2-TNF-	0	64,719	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD4	64,761	Neg Cont	IFN-IL2-TNF+	1	1	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD4	64,761	Neg Cont	IFN-IL2+TNF+	2	2	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD4	64,761	Neg Cont	IFN+IL2-TNF-	1	15	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD4	64,761	Neg Cont	IFN+IL2-TNF+	2	1	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD4	64,761	Neg Cont	IFN+IL2+TNF-	2	15	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD4	64,761	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD8	65,384	Neg Cont	IFN-IL2-TNF-	0	65,365	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD8	65,384	Neg Cont	IFN-IL2-TNF+	1	1	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD8	65,384	Neg Cont	IFN-IL2+TNF+	2	0	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD8	65,384	Neg Cont	IFN+IL2-TNF-	1	12	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD8	65,384	Neg Cont	IFN+IL2-TNF+	2	1	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD8	65,384	Neg Cont	IFN+IL2+TNF-	2	5	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD8	65,384	Neg Cont	IFN+IL2+TNF+	3	0	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD4	64,761	Neg Cont	IFN-IL2+TNF-	1	8	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-3	ICS003	Blinded	2006-03-27 00:00	Y	Y	A	P1	3	C02	251,238	244,697	222,047	194,808	147,188	CD8	65,384	Neg Cont	IFN-IL2+TNF-	1	0	2	1	S	N	9264	118785.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-4	ICS004	Blinded	2006-03-27 00:00	Y	Y	A	P1	4	D01	227,396	221,191	202,907	156,986	128,116	CD4	72,742	Neg Cont	IFN-IL2-TNF-	0	72,695	1	1	S	N	9265	118789.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-4	ICS004	Blinded	2006-03-27 00:00	Y	Y	A	P1	4	D01	227,396	221,191	202,907	156,986	128,116	CD4	72,742	Neg Cont	IFN-IL2-TNF+	1	4	1	1	S	N	9265	118789.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-4	ICS004	Blinded	2006-03-27 00:00	Y	Y	A	P1	4	D01	227,396	221,191	202,907	156,986	128,116	CD4	72,742	Neg Cont	IFN-IL2+TNF+	2	1	1	1	S	N	9265	118789.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-4	ICS004	Blinded	2006-03-27 00:00	Y	Y	A	P1	4	D01	227,396	221,191	202,907	156,986	128,116	CD4	72,742	Neg Cont	IFN+IL2-TNF-	1	14	1	1	S	N	9265	118789.fcs
PV1	FH	L02-060329-PV1-R1	L02-060329-PV1-R1-4	ICS004	Blinded	2006-03-27 00:00	Y	Y	A	P1	4	D01	227,396	221,191	202,907	156,986	128,116	CD4	72,742	Neg Cont	IFN+IL2-TNF+	2	1	1	1	S	N	9265	118789.fcs

LabKey Support

LabKey Support

Summary3Cytokine